NEWS

WIRES

OTHER

Unresectable Colon Cancer Fuels US Markets for Colonic, Pyloric and Prostatic Stents

FARMINGTON, Conn., Aug. 5, 2011 /PRNewswire/ -- Global Information, Inc. presents a new market research report, "US Markets for Nonvascular Stents 2011" by Millennium Research Group (For more information: http://www.giiresearch.com/report/mrg203767-us-markets-nonvascular-stents-2011.html).

A key driver of the growth in colonic and duodenal/pyloric stents will be in the treatment of unresectable colon cancer, which is increasing in incidence and cannot be treated with surgery. Rising physician awareness of the benefits of stenting over open surgery in general will increase demand. These benefits include less invasive treatment, higher success rates and fewer complications. Product innovations such as easier-to-deploy and covered self-expanding metal stents (SEMS) will also help drive market growth.

The US market for colonic and duodenal/pyloric stents is dominated by Boston Scientific. Cook Medical holds a much smaller share of this market, but will aim to increase its presence with the recently approved Evolution Controlled-Release Colonic and Duodenal Stent System products, which is designed to reduce the risk of perforation and migration. Other possible new SEMS competitors are M.I. Tech and Taewoong Medical, which have versions available in other countries and are expected to receive Food and Drug Administration approval for these devices as early as late 2011.

The nonvascular stent market also includes ureteral, biliary and pancreatic, esophageal, and bronchial and tracheal stents. The $185 million United States market for nonvascular stents will grow moderately over the next five years at a rate averaging just under 5% per year. The colonic, duodenal/pyloric and prostatic segments will grow much more dramatically, with each of them yielding more than 15% average annual revenue growth through 2015.

The report includes procedure, unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for ureteral, biliary and pancreatic, esophageal, colonic and duodenal/pyloric, bronchial and tracheal and prostatic stents in the United States.

Find more catheter equipment market research reports: http://www.giiresearch.com/topics/MC05_en.shtml

Browse medical device market research reports: http://www.giiresearch.com/medical_device_report.shtml

About Global Information, Inc. (GII)
Global Information, Inc. has been in the business of distributing technical and market research for more than 25 years.

Contact Information:
+1-860-674-8796
Email: Press@gii.co.jp

Media Contact Info:
Yuko Ueki
Global Information, Inc.
860-674-8796
http://www.giiresearch.com/about_en.shtml
Press@gii.co.jp

SOURCE Global Information, Inc.